CN103070338A - 一种蓝莓咀嚼片 - Google Patents
一种蓝莓咀嚼片 Download PDFInfo
- Publication number
- CN103070338A CN103070338A CN2013100583725A CN201310058372A CN103070338A CN 103070338 A CN103070338 A CN 103070338A CN 2013100583725 A CN2013100583725 A CN 2013100583725A CN 201310058372 A CN201310058372 A CN 201310058372A CN 103070338 A CN103070338 A CN 103070338A
- Authority
- CN
- China
- Prior art keywords
- blueberry
- chewable tablets
- chewable tablet
- mixing
- maltodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000003095 Vaccinium corymbosum Nutrition 0.000 title claims abstract description 48
- 235000017537 Vaccinium myrtillus Nutrition 0.000 title claims abstract description 48
- 235000021014 blueberries Nutrition 0.000 title claims abstract description 48
- 239000007910 chewable tablet Substances 0.000 title claims abstract description 25
- 229940068682 chewable tablet Drugs 0.000 title abstract 4
- 244000077233 Vaccinium uliginosum Species 0.000 title description 19
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 29
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 18
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 9
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 9
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 9
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 9
- 229940055416 blueberry extract Drugs 0.000 claims description 13
- 235000019216 blueberry extract Nutrition 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 9
- 235000021552 granulated sugar Nutrition 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- 235000020985 whole grains Nutrition 0.000 claims description 7
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000010298 pulverizing process Methods 0.000 abstract description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 235000021551 crystal sugar Nutrition 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 238000003825 pressing Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 210000001508 eye Anatomy 0.000 description 15
- 230000004438 eyesight Effects 0.000 description 15
- 230000036541 health Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 208000003464 asthenopia Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 229930014669 anthocyanidin Natural products 0.000 description 6
- 150000001453 anthocyanidins Chemical class 0.000 description 6
- 235000008758 anthocyanidins Nutrition 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000002932 luster Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 230000004436 pseudomyopia Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004330 Rhodopsin Human genes 0.000 description 2
- 108090000820 Rhodopsin Proteins 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000000496 cardiotonic agent Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 210000000196 olfactory nerve Anatomy 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010009185 Ciliary muscle spasm Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 239000012677 causal agent Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013100583725A CN103070338B (zh) | 2013-02-25 | 2013-02-25 | 一种蓝莓咀嚼片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013100583725A CN103070338B (zh) | 2013-02-25 | 2013-02-25 | 一种蓝莓咀嚼片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103070338A true CN103070338A (zh) | 2013-05-01 |
CN103070338B CN103070338B (zh) | 2013-11-27 |
Family
ID=48147200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013100583725A Active CN103070338B (zh) | 2013-02-25 | 2013-02-25 | 一种蓝莓咀嚼片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103070338B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103494134A (zh) * | 2013-08-28 | 2014-01-08 | 沈阳农业大学 | 一种缓解视力疲劳蓝莓含片及其制作方法 |
CN104366328A (zh) * | 2014-11-07 | 2015-02-25 | 柳城县天地自然食品有限公司 | 一种蓝莓茯苓咀嚼片及制备方法 |
CN104522645A (zh) * | 2014-12-09 | 2015-04-22 | 大兴安岭至臻尚品寒带生物技术有限公司 | 一种蓝莓花青素片的配方及生产工艺 |
CN104621552A (zh) * | 2013-11-12 | 2015-05-20 | 江苏艾兰得营养品有限公司 | 一种保护及改善视力的咀嚼片及其制备方法 |
CN104814995A (zh) * | 2015-05-12 | 2015-08-05 | 沈小玲 | 一种南烛子粉保健品组合物及其制备方法与应用 |
CN105533316A (zh) * | 2014-11-04 | 2016-05-04 | 威海特伦斯生物工程有限公司 | 一种缓解视疲劳的蓝莓咀嚼片生产方法 |
CN106036626A (zh) * | 2016-06-16 | 2016-10-26 | 湖北工业大学 | 一种桑葚紫酒泥咀嚼片的制备方法 |
CN106343548A (zh) * | 2016-08-24 | 2017-01-25 | 东北林业大学 | 一种甘草黄酮复合蓝莓汁咀嚼片及其制备方法 |
CN110522030A (zh) * | 2019-10-12 | 2019-12-03 | 烟台华康海洋食品有限公司 | 一种海参营养咀嚼片及其制备方法 |
CN110710673A (zh) * | 2019-09-26 | 2020-01-21 | 南宁海王健康生物科技有限公司 | 蓝莓复合维生素c咀嚼片及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1759745A (zh) * | 2005-10-11 | 2006-04-19 | 辽宁红树莓产业发展有限公司 | 蓝莓保健功能食品及其制备方法 |
CN101385769A (zh) * | 2008-10-24 | 2009-03-18 | 上海应用技术学院 | 蓝莓珍珠咀嚼片及其制备方法 |
-
2013
- 2013-02-25 CN CN2013100583725A patent/CN103070338B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1759745A (zh) * | 2005-10-11 | 2006-04-19 | 辽宁红树莓产业发展有限公司 | 蓝莓保健功能食品及其制备方法 |
CN101385769A (zh) * | 2008-10-24 | 2009-03-18 | 上海应用技术学院 | 蓝莓珍珠咀嚼片及其制备方法 |
Non-Patent Citations (1)
Title |
---|
左曙辉等: "膳食补充片剂(胶囊)的生产", 《中国食品添加剂》 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103494134A (zh) * | 2013-08-28 | 2014-01-08 | 沈阳农业大学 | 一种缓解视力疲劳蓝莓含片及其制作方法 |
CN103494134B (zh) * | 2013-08-28 | 2015-06-24 | 沈阳农业大学 | 一种缓解视力疲劳蓝莓含片的制作方法 |
CN104621552A (zh) * | 2013-11-12 | 2015-05-20 | 江苏艾兰得营养品有限公司 | 一种保护及改善视力的咀嚼片及其制备方法 |
CN105533316A (zh) * | 2014-11-04 | 2016-05-04 | 威海特伦斯生物工程有限公司 | 一种缓解视疲劳的蓝莓咀嚼片生产方法 |
CN104366328A (zh) * | 2014-11-07 | 2015-02-25 | 柳城县天地自然食品有限公司 | 一种蓝莓茯苓咀嚼片及制备方法 |
CN104522645A (zh) * | 2014-12-09 | 2015-04-22 | 大兴安岭至臻尚品寒带生物技术有限公司 | 一种蓝莓花青素片的配方及生产工艺 |
CN104814995A (zh) * | 2015-05-12 | 2015-08-05 | 沈小玲 | 一种南烛子粉保健品组合物及其制备方法与应用 |
CN106036626A (zh) * | 2016-06-16 | 2016-10-26 | 湖北工业大学 | 一种桑葚紫酒泥咀嚼片的制备方法 |
CN106343548A (zh) * | 2016-08-24 | 2017-01-25 | 东北林业大学 | 一种甘草黄酮复合蓝莓汁咀嚼片及其制备方法 |
CN106343548B (zh) * | 2016-08-24 | 2019-08-02 | 东北林业大学 | 一种甘草黄酮复合蓝莓汁咀嚼片及其制备方法 |
CN110710673A (zh) * | 2019-09-26 | 2020-01-21 | 南宁海王健康生物科技有限公司 | 蓝莓复合维生素c咀嚼片及其制备方法 |
CN110522030A (zh) * | 2019-10-12 | 2019-12-03 | 烟台华康海洋食品有限公司 | 一种海参营养咀嚼片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103070338B (zh) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103070338B (zh) | 一种蓝莓咀嚼片 | |
CN104509899A (zh) | 一种莲藕蓝莓饮料 | |
CN104366174A (zh) | 一种绿豆香蕉果冻的制作方法 | |
CN101103830A (zh) | 一种南瓜、甜玉米饮料及其制备方法 | |
CN101744189A (zh) | 一种纳豆及其制备方法 | |
CN103478200A (zh) | 一种玫瑰花紫薯饼干 | |
CN107183290A (zh) | 一种黑枸杞压片糖果及其制备方法 | |
CN104432036A (zh) | 缓解视疲劳的保健营养组合物及其制备方法与应用 | |
CN102177967A (zh) | 一种黑牛奶及其生产方法 | |
CN101411381B (zh) | 含有芦荟汁和胡萝卜汁的冷冻饮品及其制备方法 | |
CN101411422B (zh) | 番茄桃片 | |
CN101700062A (zh) | 玉米酸奶的制作方法 | |
CN103876106B (zh) | 一种低糖莲子酱及加工方法 | |
CN102870885A (zh) | 莲藕枸杞子奶茶及其制备工艺 | |
CN104286614A (zh) | 一种护肠排铅果糕的配方及加工方法 | |
CN101785505B (zh) | 一种黑豆豆奶饮料及其生产方法 | |
CN102048076A (zh) | 一种纯天然植物合成山药饮品 | |
CN101449824A (zh) | 蓝莓刺玫果蜂花粉食品 | |
CN102919648B (zh) | 一种营养保健型青稞果冻及其制备方法 | |
CN103988911A (zh) | 一种黑土豆水牛奶乳制品及其制备方法 | |
KR101834638B1 (ko) | 대추를 주원료로 하는 기능성 다식 제조방법 | |
CN103271353B (zh) | 一种护肝保健组合物及其制备方法 | |
CN106722891A (zh) | 一种蓝莓咀嚼片 | |
CN104116032A (zh) | 一种具有乌发养颜功效的营养早餐及其制备方法 | |
CN108354143A (zh) | 缓解视疲劳的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LIAONING QIANLIMING PHARMACEUTICAL (GROUP) CO., LT Free format text: FORMER OWNER: LIN JIHUA Effective date: 20131016 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20131016 Address after: 110000 No. 76, unity Road, Shenhe District, Liaoning, Shenyang Applicant after: Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Address before: 110000 No. 76, unity Road, Shenhe District, Liaoning, Shenyang Applicant before: Lin Jihua |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |